| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:50 UTC |
|---|
| Update Date | 2022-03-07 02:51:48 UTC |
|---|
| HMDB ID | HMDB0014958 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Tadalafil |
|---|
| Description | Tadalafil is an orally adminstered drug used to treat male erectile dysfunction (impotence). It is marketed worldwide under the brand name Cialis. It is a phosphodiesterase 5 (PDE5) inhibitor. Tadalafil's distinguishing pharmacologic feature is its longer half-life (17.5 hours) compared with Viagra and Levitra (4-5 hours). This longer half-life results in a longer duration of action and is, in part, responsible for the Cialis nickname of the 'weekend pill.' This longer half-life also is the basis of current investigation for tadalafil's use in pulmonary arterial hypertension as a once-daily therapy. [Wikipedia ] |
|---|
| Structure | [H][C@]12CC3=C(NC4=CC=CC=C34)[C@H](N1C(=O)CN(C)C2=O)C1=CC2=C(OCO2)C=C1 InChI=1S/C22H19N3O4/c1-24-10-19(26)25-16(22(24)27)9-14-13-4-2-3-5-15(13)23-20(14)21(25)12-6-7-17-18(8-12)29-11-28-17/h2-8,16,21,23H,9-11H2,1H3/t16-,21-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione | ChEBI | | (6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione | ChEBI | | 6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione | ChEBI | | Adcirca | ChEBI | | Cialis | ChEBI | | Zalutia | Kegg | | ICOS 351 | HMDB | | Tadanafil | HMDB | | 351, IC | HMDB |
|
|---|
| Chemical Formula | C22H19N3O4 |
|---|
| Average Molecular Weight | 389.404 |
|---|
| Monoisotopic Molecular Weight | 389.137556111 |
|---|
| IUPAC Name | (2R,8R)-2-(2H-1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(10),11,13,15-tetraene-4,7-dione |
|---|
| Traditional Name | tadalafil |
|---|
| CAS Registry Number | 171596-29-5 |
|---|
| SMILES | [H][C@]12CC3=C(NC4=CC=CC=C34)[C@H](N1C(=O)CN(C)C2=O)C1=CC2=C(OCO2)C=C1 |
|---|
| InChI Identifier | InChI=1S/C22H19N3O4/c1-24-10-19(26)25-16(22(24)27)9-14-13-4-2-3-5-15(13)23-20(14)21(25)12-6-7-17-18(8-12)29-11-28-17/h2-8,16,21,23H,9-11H2,1H3/t16-,21-/m1/s1 |
|---|
| InChI Key | WOXKDUGGOYFFRN-IIBYNOLFSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as beta carbolines. Beta carbolines are compounds containing a 9H-pyrido[3,4-b]indole moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Indoles and derivatives |
|---|
| Sub Class | Pyridoindoles |
|---|
| Direct Parent | Beta carbolines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Beta-carboline
- Alpha-amino acid or derivatives
- 3-alkylindole
- Benzodioxole
- Indole
- 2,5-dioxopiperazine
- Dioxopiperazine
- N-methylpiperazine
- N-alkylpiperazine
- Benzenoid
- Piperazine
- 1,4-diazinane
- Tertiary carboxylic acid amide
- Pyrrole
- Heteroaromatic compound
- Carboxamide group
- Lactam
- Acetal
- Carboxylic acid derivative
- Oxacycle
- Azacycle
- Hydrocarbon derivative
- Organic nitrogen compound
- Organic oxide
- Carbonyl group
- Organopnictogen compound
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 301 - 302 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.25 g/L | Not Available | | LogP | 1.7 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections| Adduct Type | Data Source | CCS Value (Å2) | Reference |
|---|
| [M+H]+ | CBM | 189.4 | 30932474 |
|
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 6.46 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 13.8185 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.88 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2420.4 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 302.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 191.1 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 198.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 188.3 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 559.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 607.0 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 130.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1163.2 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 507.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1638.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 373.0 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 392.5 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 326.9 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 173.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 9.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Tadalafil,1TMS,isomer #1 | CN1CC(=O)N2[C@H](CC3=C([C@H]2C2=CC=C4OCOC4=C2)N([Si](C)(C)C)C2=CC=CC=C32)C1=O | 3619.5 | Semi standard non polar | 33892256 | | Tadalafil,1TMS,isomer #1 | CN1CC(=O)N2[C@H](CC3=C([C@H]2C2=CC=C4OCOC4=C2)N([Si](C)(C)C)C2=CC=CC=C32)C1=O | 3613.8 | Standard non polar | 33892256 | | Tadalafil,1TMS,isomer #1 | CN1CC(=O)N2[C@H](CC3=C([C@H]2C2=CC=C4OCOC4=C2)N([Si](C)(C)C)C2=CC=CC=C32)C1=O | 4812.1 | Standard polar | 33892256 | | Tadalafil,1TBDMS,isomer #1 | CN1CC(=O)N2[C@H](CC3=C([C@H]2C2=CC=C4OCOC4=C2)N([Si](C)(C)C(C)(C)C)C2=CC=CC=C32)C1=O | 3799.5 | Semi standard non polar | 33892256 | | Tadalafil,1TBDMS,isomer #1 | CN1CC(=O)N2[C@H](CC3=C([C@H]2C2=CC=C4OCOC4=C2)N([Si](C)(C)C(C)(C)C)C2=CC=CC=C32)C1=O | 3866.6 | Standard non polar | 33892256 | | Tadalafil,1TBDMS,isomer #1 | CN1CC(=O)N2[C@H](CC3=C([C@H]2C2=CC=C4OCOC4=C2)N([Si](C)(C)C(C)(C)C)C2=CC=CC=C32)C1=O | 4838.0 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Tadalafil GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-3097000000-803ff86b2ce502e2bc83 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tadalafil GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Tadalafil GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil LC-ESI-qTof , Positive-QTOF | splash10-02t9-2890000000-0be3708ad44a8a467cc5 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil Linear Ion Trap , negative-QTOF | splash10-03di-0090000000-c52485d22b5893fc60a2 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil Linear Ion Trap , negative-QTOF | splash10-03di-0090000000-2f6ad2194cd2932b0761 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil Linear Ion Trap , positive-QTOF | splash10-0i0r-0291000000-a4ae40141abccfc86710 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil Linear Ion Trap , positive-QTOF | splash10-0j59-0290000000-86095fe2d98833db9d0b | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil Linear Ion Trap , positive-QTOF | splash10-0uy0-0429200000-641774545afc89315134 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil Linear Ion Trap , positive-QTOF | splash10-0uy0-0429200000-f223c860e93cceeeacd8 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil , positive-QTOF | splash10-014i-0292000000-0563bdd5b0be8c1cfa47 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil , positive-QTOF | splash10-02t9-2890000000-0be3708ad44a8a467cc5 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil 35V, Positive-QTOF | splash10-014i-0391000000-2d53d99ea189cbcf20bf | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil 10V, Positive-QTOF | splash10-0f6x-0009000000-bea170f3de4098be75e0 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil 40V, Positive-QTOF | splash10-001i-0191000000-b10465a3e1f68719ab50 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil 20V, Positive-QTOF | splash10-0udi-0019000000-989b326813e322333fa5 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil 20V, Negative-QTOF | splash10-004i-0119000000-28b2b617eb618183d5c8 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil 40V, Negative-QTOF | splash10-001i-0791000000-5534e9b8d8ed5169e623 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil 10V, Negative-QTOF | splash10-000i-0009000000-844cd3bb8e0273b1cadd | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tadalafil 35V, Negative-QTOF | splash10-03di-0091000000-612762fb281177438c8e | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tadalafil 10V, Positive-QTOF | splash10-0006-0009000000-cfa5abcf4ec76ea41d68 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tadalafil 20V, Positive-QTOF | splash10-0006-1019000000-59cc81b34404c6ecd167 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tadalafil 40V, Positive-QTOF | splash10-0006-0291000000-20d1a51d47c7345d5742 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tadalafil 10V, Negative-QTOF | splash10-000i-2009000000-721840625f2b26eb19a7 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tadalafil 20V, Negative-QTOF | splash10-052r-4019000000-5dff72997668963ef319 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tadalafil 40V, Negative-QTOF | splash10-01pc-2191000000-f8bd70ef77444b35f09b | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tadalafil 10V, Positive-QTOF | splash10-0006-0029000000-5ec0e4346a39de6e6582 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tadalafil 20V, Positive-QTOF | splash10-0006-0009000000-565961b51e5cb53f55d4 | 2021-10-11 | Wishart Lab | View Spectrum |
|
|---|